Biorez
Company

Last deal

$3.5M

Amount

Seed

Stage

14.09.2020

Date

3

all rounds

$26.43M

Total amount

date founded

Financing round

General

About Company
Biorez is a medicine company that develops bio-inductive implants to rebuild functional tissue and improve musculoskeletal outcomes.

Industry

Sector :

Subsector :

Also Known As

Soft Tissue Regeneration Inc.

founded date

01.01.2008

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

The company's patented and proprietary technology uses a degradable polymer, PLLA, to create orthopedic implant devices for soft tissue regeneration and augmentation. Biorez has developed a suite of associated products, including the biorez GRAFT™, a FDA 510(k)-cleared device for soft tissue augmentation of the rotator cuff. Their BioBrace™ scaffold has been engineered to facilitate tissue regeneration and reinforce tendon and ligament repairs. Biorez is committed to helping patients return to full activity sooner and safer following debilitating ligament and tendon injuries.
Contacts

Contact Email

Social url

Similar Companies
999
MateraCor

MateraCor

MateraCor is a start-up developing innovative ways to prevent and reverse heart failure.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Biotechnology, Medical Device

Location

Aliso Viejo, CA, USA
NovoPedics

NovoPedics

NovoPedics is a US-based biotech company that develops implantable medical devices for meniscus replacement and regeneration.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Biotechnology, Medical Device

Location

Washington Cir NW, Washington, DC, USA

total rounds

1

total raised

$500K
DEBN

DEBN

DEBN develops a prostate biopsy needle that reduces infectious complications.

Sector

Medical Equipment and Services

Subsector

Medical Supplies

Location

Gdańsk, Poland

total rounds

2
Embody

Embody

Embody Inc develops implantable medical devices for soft tissue restoration and regeneration.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Medical Device, Health Care, Biotechnology

Location

Norfolk, VA, USA

total rounds

8

total raised

$47.8M
M&A Details
1

Transaction name

Acquired by

CONMED

announced date

01.08.2022

price

$85M

Financials

Funding Rounds
8
3

Number of Funding Rounds

$26.43M

Money Raised

Their latest funding was raised on 14.09.2020. Their latest investor Dane Miller. Their latest round Seed

Date 
Funding Round 
Investors 
Money Raised 
Lead 
New York Angels

New York Angels

New York Angels is a professional angel organization that finds, funds, and mentors early-stage companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

New York, NY, USA

count Of Investments

199

count Of Exists

42
New York Angels

New York Angels

New York Angels is a professional angel organization that finds, funds, and mentors early-stage companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

New York, NY, USA

count Of Investments

199

count Of Exists

42
The Vertical Group

The Vertical Group

The Vertical Group is a venture capital firm focused on medical technology and biotechnology.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Biotechnology, Financial Services, Medical

Location

Basking Ridge, Bernards, NJ 07920, USA

count Of Investments

51

count Of Exists

18
Connecticut Innovations

Connecticut Innovations

Connecticut Innovations provides strategic capital and operational insight to high-tech companies in Connecticut.

Sector

General Industrials

Subsector

Diversified Industrials

Location

Rocky Hill, CT, USA

count Of Investments

287

count Of Exists

47
LaunchCapital

LaunchCapital

LaunchCapital invests in seed-stage entrepreneurs who are building the future.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

New Haven, CT, USA

count Of Investments

206

count Of Exists

61
Co-Investors
Investors
7
4

Number of lead investors

7

Number of investors

Investor 
Lead 
Round 
Partners 
No
Venture - Series Unknown
Yes
Seed, Series C
Yes
Seed, Series C
Dane Miller

Dane Miller

Dane Miller received his B.S. Degree in Mechanical Materials Science Engineering from General Motors Institute in 1969. He then received a Masters Degree and Ph.D. in Materials Science-Biomedical Engineering from the University of Cincinnati in 1971 and 1974, respectively. Dr. Miller began his professional career at the Frigidaire Division, GMC in Dayton, Ohio from 1964 to 1969, working as a cooperative engineering student. From 1972 to 1975 he was employed at Zimmer U.S.A. in Warsaw, Indiana, in the position of Director of Biomedical Engineering. His responsibilities included engineering, prototype design and fabrication, as well as basic research support for all new product development programs. He was also responsible for coordinating and developing a custom and special product group, including marketing, sales, and manufacturing of custom products. From 1975 to 1978, Dr. Miller served as Director of Biomedical Engineering for Cutter Biomedical, a division of Cutter Laboratories, Inc., in San Diego, California. His responsibilities included organizing and staffing of a complete product development group, including formal budgeting and product planning functions. Finally, in 1978, Dr. Miller returned to Warsaw and, along with three other local individuals with orthopedic manufacturing experience formed Biomet, Inc. Their goal was to become the most responsive company in orthopedics while simultaneously providing patients with the highest quality and most clinically proven products in the marketplace. Since its inception in 1978 until March of 2006 Dr. Miller served as President and CEO of the company. With Dr. Miller at the helm, Biomet grew from $17,000 in sales its first year into one of the leading musculoskeletal companies in the world – with annual sales exceeding $2.7 billion. Since his retirement, Dr. Miller has participated with a group of private equity sponsors taking Biomet private in September of 2007 and serves on the Biomet Board of Directors.

current job

BioMet
BioMet

count Of Investments

1

count Of Exists

1
New York Angels

New York Angels

New York Angels is a professional angel organization that finds, funds, and mentors early-stage companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

New York, NY, USA

count Of Investments

199

count Of Exists

42
The Vertical Group

The Vertical Group

The Vertical Group is a venture capital firm focused on medical technology and biotechnology.

Sector

General Industrials

Subsector

Diversified Industrials

Keywords

Biotechnology, Financial Services, Medical

Location

Basking Ridge, Bernards, NJ 07920, USA

count Of Investments

51

count Of Exists

18

People

Founders
2
Joseph W. Reilly
Joseph W. Reilly

Joseph W. Reilly

Mr. Reilly serves as our President and Chief Executive Officer. Mr. Reilly is a proven CEO/Entrepreneur who had previously been involved in a successful start up of a Biotech/Life Sciences company. He possesses significant skills in strategy development and execution, planning, marketing, sales and operations with significant M&A and turnaround experience. He is a startup specialist who served as President and CEO of a startup biotech company, Theranostics Health, which included technology spun out of George Mason University. Previously, he served as Managing Director of The Chatham Group, LLC where he advised numerous private equity firms and financial buyers on acquisitions of energy and infrastructure-related assets and companies. He also served as the President and CEO of a market leading composite technologies company, which designed, developed and marketed innovative composite products to the utility and telecommunications industries. Previously, he was the President of a privately owned international manufacturing business. In the 1980’s, Mr. Reilly was an executive and investor in three Forstmann Little & Co. leveraged buyouts: Lear Seigler Corp., Midland Ross Corp. and F.L. Industries, having a combined transaction value in excess of $4 billion. Mr. Reilly is a Certified Public Accountant. He received a BS in Accounting and an MBA from St. John’s University.

current job

Biorez
Biorez

Joseph W. Reilly

Cato T. Laurencin

current job

Biorez
Biorez

organization founded

1

Cato T. Laurencin

Employee Profiles
6
Kevin Rocco

Kevin Rocco

Chief Executive Officer

Joseph W. Reilly

Joseph W. Reilly

Founder, President &CEO

Cato T. Laurencin

Founder

Anjali Jalota

Anjali Jalota

Clinical Affairs Consultant

Bhavana Mohanraj

Bhavana Mohanraj

Biomedical Engineer

Robert Poggie

Robert Poggie

Regulatory and R&D

Activity

Recent News
1